Barclays Portfolio holdings
Barclays is a British universal bank whose roots go back to 1690, when the Quakers John Freame and Thomas Gould started a goldsmith banking business in London. The Barclays name came into the business in 1736, when James Barclay, son-in-law of founder John Freame, became a partner. Barclays launched the UK's first credit card, Barclaycard, in 1966, and in 1967 put the world's first cash machine in a branch in Enfield. In 2008 Barclays bought the North American operations of Lehman Brothers, and in 2009 it sold its Barclays Global Investors unit, home of the iShares ETFs, to BlackRock. It runs five divisions: UK consumer banking, UK corporate banking, private banking and wealth management, an investment bank and a US consumer bank.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$17.5B |
| 2 |
NVIDIA
NVDA
|
+$2.7B |
| 3 |
Intel
INTC
|
+$1.98B |
| 4 |
Broadcom
AVGO
|
+$1.46B |
| 5 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$1.11B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI Emerging Markets ETF
EEM
|
+$35.8B |
| 2 |
Apple
AAPL
|
+$1.83B |
| 3 |
Invesco QQQ Trust
QQQ
|
+$913M |
| 4 |
Microsoft
MSFT
|
+$856M |
| 5 |
Bank of America
BAC
|
+$792M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 49.47% |
| 2 | Technology | 19.84% |
| 3 | Consumer Discretionary | 7.61% |
| 4 | Financials | 5.61% |
| 5 | Communication Services | 3.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1876
Celanese
CE
$5.64B
| $6.77M | ﹤0.01% |
152,516
+69,871
| +85% | +$3.19M |
2013 Q2
53 quarters
|
|
1877
iShares MSCI World ETF
URTH
$9.7B
| $6.75M | ﹤0.01% |
32,730
| – | – |
2026 Q1
2 quarters
|
|
1878
PVH
PVH
$4.31B
| $6.72M | ﹤0.01% |
90,694
+65,291
| +257% | +$5.1M |
2013 Q2
53 quarters
|
|
1879
Boeing Co 6.00% Series A Preferred Stock
BA.PRA
$6.25B
| $6.71M | ﹤0.01% |
113,468
-117,156
| -51% | -$7.79M |
2024 Q4
7 quarters
|
|
1880
Federated Hermes
FHI
$4.71B
| $6.71M | ﹤0.01% |
118,999
+91,549
| +334% | +$5.53M |
2022 Q3
16 quarters
|
|
1881
Patterson-UTI
PTEN
$4.16B
| $6.68M | ﹤0.01% |
612,157
+250,901
| +69% | +$2.75M |
2013 Q2
53 quarters
|
|
1882
V2X
VVX
$2.52B
| $6.68M | ﹤0.01% |
94,423
-50,607
| -35% | -$3.95M |
2014 Q3
48 quarters
|
|
1883
Matsons
MATX
$6.18B
| $6.68M | ﹤0.01% |
30,412
+17,060
| +128% | +$3.7M |
2016 Q3
40 quarters
|
|
1884
PUT
Iovance Biotherapeutics
IOVA
$3.59B
| $6.64M | ﹤0.01% |
+447,800
| New | +$3.2M |
2026 Q3
0 quarters
|
|
1885
CALL
Globalstar
GSAT
$11.2B
| $6.63M | ﹤0.01% |
80,000
| – | – |
2026 Q2
1 quarter
|
|
|
1886
PUT
Globalstar
GSAT
$11.2B
| $6.63M | ﹤0.01% |
80,000
| – | – |
2026 Q2
1 quarter
|
|
1887
Direxion Daily MU Bull 2X ETF
MUU
$2.15B
| $6.62M | ﹤0.01% |
179,756
+17,356
| +11% | +$549K |
2026 Q1
2 quarters
|
|
1888
The GEO Group
GEO
$4.28B
| $6.62M | ﹤0.01% |
217,122
+192,654
| +787% | +$5.96M |
2014 Q3
48 quarters
|
|
1889
CALL
CVS Health
CVS
$114B
| $6.56M | ﹤0.01% |
76,600
+20,300
| +36% | +$1.99M |
2023 Q3
12 quarters
|
|
1890
Ginkgo Bioworks
DNA
$623M
| $6.56M | ﹤0.01% |
511,416
+481,450
| +1,607% | +$3.92M |
2022 Q1
18 quarters
|
|
1891
PUT
Dollar General
DG
$29.6B
| $6.54M | ﹤0.01% |
54,700
-17,700
| -24% | -$2.18M |
2024 Q3
8 quarters
|
|
1892
Celsius Holdings
CELH
$8.12B
| $6.54M | ﹤0.01% |
239,109
+21,815
| +10% | +$647K |
2019 Q1
30 quarters
|
|
1893
Alarm.com
ALRM
$3.21B
| $6.54M | ﹤0.01% |
120,036
+50,532
| +73% | +$2.75M |
2016 Q3
40 quarters
|
|
1894
Myers Industries
MYE
$1.06B
| $6.53M | ﹤0.01% |
212,110
+1,539
| +0.7% | +$49.3K |
2016 Q2
41 quarters
|
|
1895
AppFolio
APPF
$7.95B
| $6.48M | ﹤0.01% |
32,321
+23,710
| +275% | +$4.7M |
2017 Q1
38 quarters
|
|
1896
POSCO
PKX
$15.2B
| $6.48M | ﹤0.01% |
114,886
-28,152
| -20% | -$1.58M |
2025 Q2
5 quarters
|
|
1897
West Fraser Timber
WFG
$5.18B
| $6.48M | ﹤0.01% |
93,378
+1,942
| +2% | +$134K |
2021 Q1
22 quarters
|
|
1898
Axsome Therapeutics
AXSM
$7.45B
| $6.48M | ﹤0.01% |
35,125
-16,078
| -31% | -$3.5M |
2023 Q2
13 quarters
|
|
1899
Revolve Group
RVLV
$1.34B
| $6.46M | ﹤0.01% |
303,090
-249,193
| -45% | -$5.77M |
2019 Q2
29 quarters
|
|
1900
CNA Financial
CNA
$13.1B
| $6.46M | ﹤0.01% |
143,930
-147,936
| -51% | -$7.41M |
2015 Q2
45 quarters
|
|
Similar funds
Barclays's Q3 2026 Portfolio in Review
As of Q3 2026, Barclays held 5,855 positions worth $500B, down 4% from $521B the previous quarter. Its ten largest holdings account for 40% of the portfolio.
Barclays withdrew a net $19B in Q3 2026, closing 474 positions and reducing 1,494 holdings. Its most notable exit was ExxonMobil, an estimated $761M position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 49% of assets, down from 55% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, Barclays opened a new position in iShares Broad USD High Yield Corporate Bond ETF worth $199M.
- Barclays's largest Q3 2026 buy was iShares Broad USD High Yield Corporate Bond ETF: 5,582,517 shares worth $199M.
- Barclays added most to Tesla in Q3 2026, an estimated $17.5B increase.
- Barclays's biggest Q3 2026 reduction was iShares MSCI Emerging Markets ETF, cutting an estimated $35.8B.
- Barclays fully exited ExxonMobil in Q3 2026, selling an estimated $761M.
- Barclays's ten largest holdings make up 40% of its $500B portfolio in Q3 2026.
- Barclays opened 525 new positions and closed 474 in Q3 2026.
- Barclays's portfolio value fell 4% quarter-over-quarter to $500B.
Based on Barclays's 13F filing for Q3 2026, filed 6 Nov 2026.